---
title: "afp clinical answers"
year: 2023
month: 10
journal: "American Family Physician"
volume: "108"
issue: "10"
pages: ""
doi: ""
pmid: ""
source: "PDF Extraction"
pdf_available: true
original_pdf: "2023-10-afp-clinical-answers.pdf"
extracted_date: "2025-08-10"
keywords: []
evidence_level: ""
clinical_significance: ""
---

# afp clinical answers

                                             AFP Clinical Answers
             Menopause, Benign Prostatic Hypertrophy,
            Tuberculosis, Infertility, Child Eye Conditions

            What treatment options are available                                 trained staff to complete testing, and lower speci-
            for vasomotor symptoms associated                                    ficity and sensitivity.
            with menopause?
                                                                                             Tuberculosis; September 2022
            Estrogen-containing systemic hormone therapy
            is an effective treatment for vasomotor symptoms
            (i.e., hot flashes and night sweats). Physicians                     What is the preferred treatment for
            should prescribe the lowest effective dose for the                   latent tuberculosis infection?
            shortest duration necessary to improve symptoms                      Preferred treatment regimens for latent tuberculo-
            because of the potential risks of long-term use of                   sis infection are three to four months in duration
            hormone therapy. Nonhormonal medications,                            and include isoniazid plus rifapentine (Priftin),
            including selective serotonin reuptake inhibitors,                   rifampin alone, or isoniazid plus rifampin.
            serotonin-norepinephrine reuptake inhibitors,                                    Tuberculosis; September 2022
            fezolinetant (Veozah), gabapentin, clonidine, and
            oxybutynin, are reasonable alternatives.
                                                                                 When should you initiate a medical
              Managing Menopausal Symptoms: Common
                                                                                 evaluation for infertility?
                  Questions and Answers; July 2023
                                                                                 For female patients younger than 35 years, begin
                                                                                 evaluation after 12 months of regular, unprotected
            Which nonpharmacologic treatments                                    intercourse. For females between 35 and 40 years
            are recommended for lower urinary                                    of age, begin evaluation after six months. Immedi-
            tract symptoms due to benign                                         ate evaluation is recommended for female patients
            prostatic hypertrophy?                                               older than 40 years or in those with risk factors for
            Limiting evening fluid intake, reducing caffeine                     infertility (e.g., history of endometriosis).
            and alcohol intake, toilet and bladder training,                                       Infertility; June 2023
            sitting to urinate, urethral milking, double void-
            ing, bladder retraining, pelvic floor exercises,
            and mindfulness techniques are recommended                           How often should you screen children
            to improve symptoms.                                                 for eye conditions?
                                                                                 The U.S. Preventive Services Task Force and the
                    Benign Prostatic Hyperplasia: Rapid
                       Evidence Review; June 2023                                American Academy of Family Physicians recom-
                                                                                 mend screening children between three and five
                                                                                 years of age at least once for amblyopia or its risk
            What test should be used to screen for                               factors to improve visual acuity.
            tuberculosis in people at risk?
                                                                                       Childhood Eye Examination; July 2023
            Interferon-gamma release assay (IGRA) and
            tuberculin skin testing (TST) are the preferred
            methods of testing for tuberculosis in people                           Tip for Using AFP at the Point of Care
            at risk. Advantages of IGRA testing include no                          Do you need to refresh your procedural skills?
            requirement for a follow-up visit to interpret                          The AFP video collection includes short, edu-
            results and greater sensitivity and specificity. Dis-                   cational videos that have accompanied AFP
                                                                                    articles or were submitted as freestanding vid-
            advantages of IGRA testing include cost, and it
                                                                                    eos. All videos are peer-reviewed. Available at:
            is not recommended for use in children younger                          https://www.aafp.org/afp/videos.html.
            than two years. Advantages of TST include less                          A collection of AFP Clinical Answers is available
            expense and no need for a laboratory. Disadvan-                         at https://www.aafp.org/afp/answers.
            tages include the need for more than one visit,

Downloaded
October 2023from the American
              ◆ Volume        Family Physician
                       108, Number    4        website at www.aafp.org/afp.        © 2023 American Academy of American
                                                                            Copyright
                                                             www.aafp.org/afp                                              Family
                                                                                                               Family Physicians.     the private, 345
                                                                                                                                  ForPhysician     non-
commercial use of one individual user of the website. All other rights reserved. Contact copyrights@aafp.org for copyright questions and/or permission requests.
